Back to ATNM

Actinium Pharmaceuticals, Inc. 8-K

Accession 0001213900-22-019512

Filing information

CIK
0001388320
Report date
2022-04-07
Filing date
2022-04-13
Form
8-K
Primary document
ea158381-8k_actinium.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.